NAC (N-Acetyl Cysteine) Review 2026: Glutathione, Lungs and Safety

Affiliate links: as an Amazon Associate and through other programs, we earn from qualifying purchases, at no extra cost to you. Learn more.

Reviewed October 202611 min readEvidence-basedBy Víctor, founder · How we work
Medical disclaimer: This article is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Statements about supplements have not been evaluated by the FDA. Always consult your doctor before starting any new supplement, especially if you take medication or have a medical condition.

Quick answer: NAC (N-acetylcysteine) helps the body make glutathione and thins mucus. Its best evidence is in COPD and chronic bronchitis, where mucolytics such as NAC slightly reduced flare-ups (Poole et al., 2019); results in mental health conditions are small or mixed, and the GlyNAC trials are tiny. In hospitals NAC is an antidote for acetaminophen overdose, which is an emergency, not a reason to take NAC at home (MedlinePlus).

This review covers what NAC does, what the trials found for each use, the doses that were tested, its side effects and its legal status as a supplement in the US.

What NAC Is and How It Works

NAC is a modified form of the amino acid cysteine. It works mainly as a building block for glutathione, an antioxidant the body makes inside cells, and it can break the chemical bonds that make mucus thick, which explains its use as a mucolytic (Aldini et al., 2018).

🆕 Free Download

Get our free supplement cheat sheet.

One page: typical doses, timing and upper limits for ten well-studied supplements. No upsell.

🔒 No spam. Unsubscribe anytime. We send 1-2 emails/month max.

NAC was approved in the US as a drug in 1963. Because it was a drug first, the FDA considers it excluded from the legal definition of a dietary supplement, but in an August 2022 guidance it said it does not intend to act against products labeled as dietary supplements that contain NAC, unless they are sold to fight a disease or break other rules (FDA).

The Evidence at a Glance

UseBest evidenceWhat it found
COPD and chronic bronchitisCochrane review of 38 trials of mucolytics, NAC included (Poole et al., 2019)Small drop in flare-ups; little effect on lung function
Idiopathic pulmonary fibrosisPlacebo-controlled trial in 264 patients (Martinez et al., 2014)No benefit on lung function over 60 weeks
Acetaminophen overdoseHospital antidote (MedlinePlus)Emergency care only: call 911 or Poison Help
OCD, added to an SSRI6 small trials with 195 adults (Eghdami et al., 2024)Borderline benefit only with 5 to 8 weeks of use
Hair pulling (trichotillomania)Cochrane review of the drug trials (Hoffman et al., 2021)Helped adults in one trial, not children in another
Cannabis use disorder3 trials (Gray et al., 2012, Gray et al., 2017, Gray et al., 2025)Helped teens in one trial; not adults or youth in later trials
Depression symptomsMeta-analysis of 5 trials (Fernandes et al., 2016)Small improvement
Polycystic ovary syndrome (PCOS)Meta-analysis of 8 trials (Thakker et al., 2015)More ovulation and pregnancy than placebo, less than metformin; low-quality trials
GlyNAC (with glycine) in older adults2 small trials from one research group (Kumar et al., 2021, Kumar et al., 2023)Better lab and physical test results; too small to recommend

Lungs: COPD, Chronic Bronchitis and Lung Fibrosis

A Cochrane review of 38 trials with 10,377 adults with chronic bronchitis or COPD looked at oral mucolytics, NAC included. In the 28 trials (6,723 people) that reported it, people taking a mucolytic were more likely to stay free of flare-ups (odds ratio 1.73): about 8 people needed treatment for 9 months for one more person to stay flare-up free (Poole et al., 2019). Newer trials showed smaller benefits than older ones, and there was little effect on lung function or quality of life.

In the PANTHEON trial, 1,006 patients in China with moderate to severe COPD took 600 mg of NAC twice a day or a placebo for a year. There were 1.16 flare-ups per patient per year with NAC and 1.49 with placebo (risk ratio 0.78), and side effects were about as common as with placebo (Zheng et al., 2014). The trial was funded by a pharmaceutical company.

For idiopathic pulmonary fibrosis, a placebo-controlled trial found no benefit on lung function over 60 weeks, and an earlier arm combining prednisone, azathioprine and NAC was stopped because of safety concerns (Martinez et al., 2014). If you have a lung disease, use NAC only as part of the plan you agree with your doctor; it does not replace your prescribed medicines.

Acetaminophen Overdose Is an Emergency

In hospitals, NAC is given as an antidote for acetaminophen (paracetamol) poisoning (MedlinePlus). It is a medical treatment given after an overdose, with monitoring, and it is not a reason to take NAC at home.

MedlinePlus says there is no home treatment for an acetaminophen overdose: call 911 or the Poison Help line at 1-800-222-1222 right away. Symptoms may not appear until 12 or more hours after the acetaminophen was swallowed, treatment within 8 hours gives a very good chance of recovery, and adults should not take more than 3,000 mg of single-ingredient acetaminophen a day (MedlinePlus).

We do not recommend NAC as a liver supplement for healthy people. If you are worried about your liver, see a doctor.

Mental Health: Small and Mixed Trials

OCD: a 2024 meta-analysis of 6 randomized trials with 195 adults found a borderline benefit (p = 0.05) of NAC added to an SSRI only when it was taken for 5 to 8 weeks, and no difference for use shorter than 5 weeks or longer than 12 weeks (Eghdami et al., 2024).

Hair pulling (trichotillomania): in a 12-week trial in 50 adults, 56% were much or very much improved on 1,200 to 2,400 mg a day, compared with 16% on placebo (Grant et al., 2009). A similar trial in 39 children and teens found no benefit (Bloch et al., 2013), and a Cochrane review found the evidence too limited to confirm or rule out benefit from any medicine, describing the NAC result in adults as preliminary (Hoffman et al., 2021).

Cannabis use disorder: 1,200 mg twice a day helped 116 teens produce more negative urine tests when it was combined with a reward-based program (odds ratio 2.4) (Gray et al., 2012). It did not help 302 adults (Gray et al., 2017) or 192 young people who received brief counseling but no reward program, and in that trial more people on NAC reported stomach side effects (Gray et al., 2025).

Depression: a meta-analysis of 5 trials with 574 people found a small improvement in depression scores (standardized difference 0.37), with more minor side effects than placebo (Fernandes et al., 2016).

None of these results is strong enough to use NAC in place of care. If you have one of these conditions, talk with your doctor or psychiatrist before trying it.

PCOS and Fertility: Early, Low-Quality Evidence

In a 2015 meta-analysis of 8 trials with 910 women with PCOS, NAC led to more ovulation and pregnancy than placebo but less than metformin; several trials had a high risk of bias, and the authors called for better trials (Thakker et al., 2015). A 2025 meta-analysis of 22 studies reported changes in hormone levels and in the thickness of the womb lining (Viña et al., 2025); two of its authors work for a private wellness laboratory.

NAC does not replace care from a fertility specialist, and we found no reliable trials on it for male fertility to report here.

Doses Used in the Trials

These are the doses researchers used, often with medical follow-up. They are study doses, not personal recommendations.

ConditionDose in the trialLengthResult
COPD (PANTHEON)600 mg twice a day1 year22% fewer flare-ups (Zheng et al., 2014)
Hair pulling in adults1,200 to 2,400 mg a day12 weeks56% much improved vs 16% on placebo (Grant et al., 2009)
Cannabis use disorder in teens1,200 mg twice a day8 weeksMore negative urine tests with a reward program (Gray et al., 2012)
GlyNAC pilot in older adultsGlycine 1.33 mmol/kg and cysteine 0.81 mmol/kg a day, given as NAC24 weeksBetter lab and physical test results in 8 people, no placebo (Kumar et al., 2021)

For a 70 kg adult, the GlyNAC pilot doses work out to roughly 7 g of glycine and 9 g of NAC a day (our calculation from the per-kilogram doses).

Side Effects, Interactions and Who Should Avoid NAC

In COPD trials, side effects were about as common as with placebo: 29% vs 26% in PANTHEON (Zheng et al., 2014), and the Cochrane review found no increase in adverse events with mucolytics (Poole et al., 2019). Stomach problems can be common: in the 2025 youth trial, 63 of 98 people on NAC reported stomach side effects, compared with 37 of 94 on placebo (Gray et al., 2025).

Do not combine NAC with nitroglycerin unless your doctor manages it. In one trial, intravenous NAC given with nitroglycerin caused low blood pressure with symptoms in 7 of 24 patients, compared with none on nitroglycerin alone (Horowitz et al., 1988). In another, oral NAC with a nitroglycerin patch caused side effects in 35% of patients, mainly severe headache, about twice as often as nitroglycerin alone (Ardissino et al., 1997).

Talk to your doctor before taking NAC if you:

  • take nitroglycerin or another nitrate for chest pain;
  • have COPD, OCD, depression, PCOS or another condition that is already under a doctor’s care;
  • are pregnant or breastfeeding, since none of the trials on this page tested NAC as a supplement in pregnancy;
  • think you or someone else has taken too much acetaminophen: that is an emergency, so call 911 or Poison Help at 1-800-222-1222 (MedlinePlus).

GlyNAC: Two Small Trials From One Research Group

GlyNAC combines glycine with NAC to supply two building blocks of glutathione. The human evidence comes from one research group. Its 2021 pilot was open-label, with no placebo, in 8 older adults: after 24 weeks, glutathione, markers of oxidative stress, strength and walking speed improved, but the benefits declined 12 weeks after stopping (Kumar et al., 2021). It was funded by a philanthropic gift from a private foundation.

Its 2023 randomized trial compared GlyNAC with a placebo in 24 older adults for 16 weeks and reported improvements in the same kinds of markers and in physical function (Kumar et al., 2023); it was funded by a US National Institute on Aging grant. These trials are too small to show that GlyNAC slows aging. The earlier version of this page suggested 1,000 to 1,500 mg of NAC with 3,000 to 5,000 mg of glycine a day, a protocol that neither trial tested.

How to Choose an NAC Product

  • Check the label: compare the amount of NAC per capsule with the trial doses above, and count every product you take.
  • Choose a product sold as a dietary supplement without disease claims: the FDA policy does not cover NAC products sold to fight a disease (FDA).
  • If you are a tested athlete, choose a product certified by NSF Certified for Sport, Informed Choice or the Banned Substances Control Group; certified products are listed on their websites (NIH).

We do not lab-test products. For other supplements studied for inflammation, see our anti-inflammatory supplements guide.

Frequently Asked Questions

Is NAC the same as glutathione?

No. NAC supplies cysteine, which the body uses to make glutathione inside its cells (Aldini et al., 2018), while a glutathione supplement contains the finished molecule.

Can NAC help with COPD?

Mucolytics including NAC slightly reduced flare-ups in a Cochrane review of 38 trials, with little effect on lung function (Poole et al., 2019). Use it only as part of your doctor’s plan.

Should I take NAC at home after an acetaminophen overdose?

No. An acetaminophen overdose needs emergency care: call 911 or Poison Help at 1-800-222-1222, and hospitals give NAC as an antidote under monitoring (MedlinePlus).

Is NAC legal to sell as a supplement in the US?

The FDA says NAC is excluded from the supplement definition because it was approved as a drug in 1963. In an August 2022 guidance, it said it does not intend to act against NAC products labeled as dietary supplements, as long as they are not sold to fight a disease (FDA).

What are the side effects of NAC?

Stomach upset is common: in a 2025 trial, 63 of 98 people on NAC reported stomach side effects, compared with 37 of 94 on placebo (Gray et al., 2025). Combined with nitroglycerin, NAC caused frequent severe headaches in a heart trial, so avoid that combination unless your doctor manages it (Ardissino et al., 1997).

The Bottom Line

NAC is worth discussing with your doctor if you have COPD or chronic bronchitis, where mucolytics like it slightly reduced flare-ups. For OCD, hair pulling, cannabis use, depression and PCOS the trials are small or mixed, and the GlyNAC aging trials are tiny. Never use it at home for an acetaminophen overdose, and do not combine it with nitroglycerin on your own.

Scientific References

  1. Poole et al., 2019. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev.
  2. Aldini et al., 2018. N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why. Free Radic Res.
  3. Martinez et al., 2014. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med.
  4. Eghdami et al., 2024. The safety and efficacy of N-acetylcysteine as an augmentation in the treatment of obsessive-compulsive disorder in adults: a systematic review and meta-analysis of randomized clinical trials. Front Psychiatry.
  5. Hoffman et al., 2021. Pharmacotherapy for trichotillomania. Cochrane Database Syst Rev.
  6. Gray et al., 2012. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry.
  7. Gray et al., 2017. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend.
  8. Gray et al., 2025. N-acetylcysteine for youth cannabis use disorder: randomized controlled trial main findings. Neuropsychopharmacology.
  9. Fernandes et al., 2016. N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis. J Clin Psychiatry.
  10. Thakker et al., 2015. N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials. Obstet Gynecol Int.
  11. Kumar et al., 2021. Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial. Clin Transl Med.
  12. Kumar et al., 2023. Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial. J Gerontol A Biol Sci Med Sci.
  13. Zheng et al., 2014. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. Lancet Respir Med.
  14. Grant et al., 2009. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry.
  15. Bloch et al., 2013. N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial. J Am Acad Child Adolesc Psychiatry.
  16. Viña et al., 2025. Efficacy of N-Acetylcysteine in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis. Nutrients.
  17. Horowitz et al., 1988. Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris. Circulation.
  18. Ardissino et al., 1997. Effect of transdermal nitroglycerin or N-acetylcysteine, or both, in the long-term treatment of unstable angina pectoris. J Am Coll Cardiol.
  19. MedlinePlus Medical Encyclopedia (National Library of Medicine): Acetaminophen overdose (reviewed January 8, 2025).
  20. U.S. Food and Drug Administration: Guidance for Industry: Policy Regarding N-acetyl-L-cysteine (August 2022).
  21. NIH Office of Dietary Supplements: Dietary Supplements for Exercise and Athletic Performance, Fact Sheet for Health Professionals (updated April 1, 2024).